Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate

Cellular and Molecular Life Sciences

Volumn 66, Issue 8, 2009, Pages 1446-1456

  Sand, K L ^a   Knudsen, E ^a   Rolin, J ^a   Al Falahi, Y ^a   Maghazachi, A A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoimmunity; Cytotoxicity; Dendritic cells; Glatiramer acetate; NK cells

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLATIRAMER; HLA DR ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN P30; PROTEIN P44; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DENDRITIC CELL; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; PROTEIN SECRETION;

CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; KILLER CELLS, NATURAL; PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 67349137938     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-009-8726-1     Document Type: Article

References (28)

1. Arnon, R. and Aharoni, R. (2004) Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. USA. 101, 14593-14598
2. Aharoni, R., Teitelbaum, D., Arnon, R. and Sela, M. (2001) Copolymer 1 inhibits manifestations of graft rejection. Transplantation, 72, 598-605
3. Johnson, K. P., Brooks, B. R., Ford, C C., Goodman, A. D., Lisak, R. P., Myers, L. W., Pruitt, A. A., Rizzo, M. A., Rose, J. W., Weiner, L. P. and Wolinsky, J. S. (2003) Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial. Mult. Scler. 9, 585-591
4. Valenzuela, R. M., Costello, K., Chen, M., Said, A., Johnson, K. P. and Dhib-Jalbut, S. (2007) Clinical,response to glatiramer acetate correlates with modulation of IFN-γ and IL-4 expression in multiple sclerosis. Mult. Scler. 13, 754-762
5. Hong, J., Li, N., Zhang, X., Zheng, B. and Zhang, J. Z. (2005) Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. USA. 102, 6449-6454
6. Vieira, P. L., Heystek, H. C., Wormmeester, J., Wierenga, E. A. and Kapsenberg, M. L. (2003) Glatiramer acetate (copolymer1, Copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170, 4483-4488
7. Weber, M. S., Starek, M., Wagenpfeil, S., Meinl, E., Hohlfeld, R. and Farina, C (2004) Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127, 1370-1378
8. Kim, H. J., Ifergan, I., Antel, J. P., Seguin, R., Duddy, M., Lapierre, Y Jailli, F. and Bar-Or, A. (2004) Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J. Immunol, 172, 7144-7153
9. Weber, M.S., Prod'homme, T., Youssef, S., Dunn, S., Rundle, C D., Lee, L., Patarroyo, J. C., Stuve, O., Sobel, R. A., Steinman, L. and Zamvil, S. S. (2007) Type II monocytes modulate T cell-mediated central nervous sytem autoimmune disease. Nat. Med. 13, 935-943
10. Maghazachi, A. A. (2003). G protein-coupled receptors in natural killer cells. J. Leukoc. Biol. 74, 16-24
11. Maghazachi, A. A. (2005) Insights into seven and single transmembrane-spanning domain receptors and their signalling pathways in human natural killer cells. Pharmacol. Rev. 57, 339-357
12. Zhang, B.-n., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T. (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med.186, 1677-1687
13. Huang, D., Shi, R D., Jung, S., Pien, G. C., Wang, J., SalazarMather, T. P., He, T. T., Weaver, J. T., Ljunggren, H.-G., Biron, C A., Littman, D. R. and Ransohoff, R. M. (2006) The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896-905
14. Pagenstecher, A., Lassmann, S., Carson, M. J., Kincaid, C L., Stalder, A. K. and Campbell, I. L. (2000) Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. J. Immunol. 1.64, 4481-4492
15. Shi, F-D., Takeda, K., Akira, S., Sarvetnick, N. and Ljunggren, H.-G. (2000) IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-γ by NK cells. J. Immunol. 165, 3099-3104
16. Al-Falahi, Y., Sand, K., L., Knudsen, E., Damaj, B. B., Rolin, J. and Maghazachi, A. A. (2009) Splenic natural killer cell activity in two models of experimental neurodegenerative diseases. J. Cell. Mol. Med. Published online (29 Dec 2008)
17. Oz-Arslan, D., Rüscher, W., Myrtek, D., Ziemer, M., Jin, Y., Damaj, B. B., Sorichter, S., Idzko, M., Norgauer, J. and Maghazachi, A. A. (2006) IL-6 and IL-8 release is mediated via multiple signaling pathways after stimulating dendritic cells with lysophospholipids. J. Leukoc. Biol. 80, 287-297
18. Damaj, B. B., Becerra, C B., Esber, H. J., Wen, Y and Maghazachi, A. A. (2007) Functional expression of H4 histmaine receptor in human natural, killer cells, monocytes, and dendritic cells. J. Immunol. 179, 7907-7915
19. Legge, K. L., Gregg, R. K., Maldonado-Lopez, R., Li, L., Caprio, J. C., Moser, M. and Zaghouani, H., (2002) On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196, 217-227
20. Menges, M., Rössner, S., Voigtländer, C., Schindler, H., Kukutsch, N A., Bogdan, C., Erb, K., Schuler, G. and Lutz, M. B. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21
21. Rissoan, M.-C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., de Waal Malefyt, R. and Liu, Y. J. (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186
22. Zinser, E., Lechmann, M., Golka, A., Lutz, M. B. and Steinkasserer, A. (2004) Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200, 345-351
23. Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H. and Schwartz, M. (2006) Glatiramer acetate fights Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA. 103, 11784-11789
24. Sozzani, S., Allavena, P., Vecchi, A. and Mantovani, A. (2000) Chemokines and dendritic cell traffic. J. Clin. Immunol. 20, 151-60
25. Inngjerdingen, M, Damaj, B. and Maghazachi, A. A. (2001) Expression and regulation of chemokine receptors in human natural killer cells. Blood 97, 367-375
26. Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A. and Martin, R. (2006) Regulatory CD56bright natural, killer cells mediate immunoregulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 103, 5941-5946
27. Muraro, P. A. and Bielekova, B. (2007) Emerging therapies for multiple sclerosis. Neurotherapeutics 4, 676-92
28. Hohlfeld, R. and Wekerle, H. (2005) Drug insight: using monoclonal antibodies to treat multiple sclerosis. Nat. Clin. Practice Neurology 1, 34-41